Table 2.
Indications and types of donors for allogeneic HSCT for the year 2017 at our center
| Indications | Matched related donors | Matched unrelated donors | Haplo-identical family donor | Total |
|---|---|---|---|---|
| Thalassemia | 33 | 9 | 0 | 42 |
| Acute lymphoblastic leukemia | 12 | 5 | 9 | 26 |
| Acute myeloid leukemia | 8 | 5 | 9 | 22 |
| Acute biphenotypic leukemia/Acute leukemia of ambiguous lineage | 1 | 1 | 0 | 2 |
| Chronic myeloid leukemia | 2 | 2 | 0 | 4 |
| Chronic lymphocytic leukemia | 1 | 0 | 0 | 1 |
| Aplastic anemia | 9 | 4 | 4 | 17 |
| Congenital bone marrow failure syndromes | 5 | 1 | 3 | 9 |
| Myelodysplastic syndrome | 2 | 1 | 3 | 6 |
| Lymphomas | 5 | 0 | 1 | 6 |
| Myeloma | 1 | 0 | 0 | 1 |
| Pure red cell aplasia | 1 | 0 | 2 | 3 |
| Myelofibrosis | 1 | 1 | 2 | |
| Hemophagocytic lymphohistiocytosis | 2 | 0 | 3 | 5 |
| Gaucher disease | 1 | 0 | 2 | 3 |
| Primary immunodeficiency | 1 | 1 | 3 | 5 |
| Chediak Higashi syndrome | 1 | 0 | 0 | 1 |
| Paroxysmal noctural hemoglobinuria | 0 | 0 | 1 | 1 |
| X-linked adrenoleukodystrophy | 0 | 0 | 2 | 2 |
| Chronic granulomatous disease | 0 | 0 | 1 | 1 |
| Osteopetrosis | 0 | 0 | 1 | 1 |
| Total | 86 | 30 | 44 | 160 |